THE EFFECT OF LONG ACTING BRONCHODILATORS ON VENTILATION IN COPD

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

COPD is a common and important smoking-related lung disease. Well-established treatments with inhaled medications including long-acting bronchodilators have a proven clinical track record. However the physiological basis for their effects is still under investigation. This research examines some of the physiological changes in lung function and the response to long-acting bronchodilators in patients with COPD, and may help explain why some patients respond to therapy while others do not, leading to more targeted therapeutics

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Postgraduate Scholarships

Funding Amount: $143,676.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Systems Physiology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

airway diseases | lung function assessment | respiratory diseases | respiratory physiology | smoking-related diseases